Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study

Anne M Christensen, Jenny Bjerre, Morten Schou, Christian Jons, Michael Vinther, Gunnar H Gislason, Jens B Johansen, Jens C Nielsen, Helen H Petersen, Sam Riahi, Anne-Christine Ruwald

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalEuropace
Volume21
Issue number3
Pages (from-to)465–474
Number of pages10
ISSN1099-5129
DOIs
Publication statusPublished - 1 Mar 2019

    Fingerprint

Bibliographical note

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Keywords

  • Appropriate implantable cardioverter-defibrillator therapy
  • Heart failure
  • Mortality
  • Oncology
  • Patient selection
  • Prognosis

Cite this

Christensen, A. M., Bjerre, J., Schou, M., Jons, C., Vinther, M., Gislason, G. H., Johansen, J. B., Nielsen, J. C., Petersen, H. H., Riahi, S., & Ruwald, A-C. (2019). Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study. Europace, 21(3), 465–474. https://doi.org/10.1093/europace/euy268